Physicians and researchers at Cincinnati Children’s offer clinical research studies for patients with sickle cell disease and other hemoglobin disorders.

We are currently building a blood and tissue bank so that we can develop better treatments for sickle cell disease. We are also testing the drug Zileuton to see if it can reduce the number of acute sickle events in patients with sickle cell disease.

Featured Clinical Trials for Sickle Cell and Hemoglobin

• A Research Study for Children (12 and older) and Adults with Sickle Cell Disease- Zileuton

• Blood and Tissue Bank